263 related articles for article (PubMed ID: 6584087)
1. [Evaluation of CA 19-9 radioimmunoassay].
Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of CA 15-3 radioimmunoassay].
Takemori Y; Odani H; Watanabe H; Ohta H; Satomura Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654
[TBL] [Abstract][Full Text] [Related]
3. [CA 19-9 enzyme immunoassay].
Ota H; Odani H; Watanabe H; Satomura Y; Takemori Y; Okai T; Sawabu N; Mai M; Hattori N; Hashimoto T
Gan No Rinsho; 1986 Aug; 32(9):993-7. PubMed ID: 3528560
[TBL] [Abstract][Full Text] [Related]
4. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
5. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
Ohuchi N; Takahashi K; Matoba N; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
[TBL] [Abstract][Full Text] [Related]
6. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].
Arakawa Y; Kobayashi H; Ozaki T; Ariga H; Matsuo Y; Honda T; Arai T; Kurosu Y; Morita K; Konuma H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110
[TBL] [Abstract][Full Text] [Related]
7. [Carbohydrate antigen CA 19-9: value in pancreatic pathology].
Venot J; Vincent D; Gainant A; Descottes B; Cessot F; Beck C
Gastroenterol Clin Biol; 1986 Mar; 10(3):208-10. PubMed ID: 3460925
[TBL] [Abstract][Full Text] [Related]
8. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
DelVillano BC; Zurawski VR
Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588
[No Abstract] [Full Text] [Related]
9. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
Ohkura H; Sakawaki T
Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
[TBL] [Abstract][Full Text] [Related]
11. [Clinical investigation of carbohydrate antigen CA-50].
Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
[No Abstract] [Full Text] [Related]
13. [Preparation and evaluation of a time-resolved fluoroimmunoassay kit for CA50 determination].
Hang JF; Wu YS; Xu WW; Yu WH; Huang Y; Li M
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):189-92. PubMed ID: 17649634
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
15. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
16. [A basic and clinical study of CA 19-9-MP-Mitsui kit for determination of CA 19-9].
Ishii M; Iida M; Seino Y
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2779-86. PubMed ID: 7993114
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
Blind PJ; Dahlgren ST
Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
[TBL] [Abstract][Full Text] [Related]
18. [Basic and clinical evaluation of CA 130 RIA kit (D-7111) using two newly developed monoclonal antibodies; comparison with CA 125 kit].
Saga T; Endo K; Nakashima T; Nakajima K; Matsuoka Y; Koizumi M; Kawamura Y; Watanabe Y; Hato A; Kunimatsu M
Kaku Igaku; 1988 Oct; 25(10):1163-70. PubMed ID: 3221514
[No Abstract] [Full Text] [Related]
19. [The diagnostic information value of determining tumor-associated antigen Ca-19-9 in pancreatic cancer].
Samoĭlenko VM; Afrikian MN; Itin AB
Vopr Onkol; 1989; 35(9):1050-3. PubMed ID: 2815692
[TBL] [Abstract][Full Text] [Related]
20. [CA 19-9, a new tumor marker].
Akai S
Rinsho Byori; 1983 Dec; 31(12):1300-2. PubMed ID: 6587136
[No Abstract] [Full Text] [Related]
[Next] [New Search]